This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 94/11/1451    most recent 01.RES.0000130654.56599.40v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lochard, N. Articles by Reudelhuber, T. L. Search for Related Content PubMed PubMed Citation Articles by Lochard, N. Articles by Reudelhuber, T. L. Related Collections ACE/Angiotension receptors Animal models of human disease Hypertension - basic studies

(Circulation Research. 2004;94:1451.)
© 2004 American Heart Association, Inc.

Integrative Physiology

Chronic Production of Angiotensin IV in the Brain Leads to Hypertension That Is Reversible With an Angiotensin II AT1 Receptor Antagonist

Nadheige Lochard, Gaétan Thibault, David W. Silversides, Rhian M. Touyz, Timothy L. Reudelhuber

From Laboratories of Molecular Biochemistry of Hypertension (N.L., T.L.R.), Cell Biology of Hypertension (G.T.), and Experimental Hypertension (R.M.T.), Clinical Research Institute of Montreal, Quebec, Canada; and Centre de Recherche en Reproduction Animale (D.W.S.), Faculté de Médecine Vétérinaire de l’université de Montréal, Sainte-Hyacinthe, Quebec, Canada.

Correspondence to Timothy L. Reudelhuber, IRCM, 110, Pine Ave West, Montreal, QC H2W 1R7 Canada. E-mail reudelt{at}ircm.qc.ca

Angiotensin IV (Ang IV) is a metabolite of the potent vasoconstrictor angiotensin II (Ang II). Because specific binding sites for this peptide have been reported in numerous tissues including the brain, it has been suggested that a specific Ang IV receptor (AT4) might exist. Bolus injection of Ang IV in brain ventricles has been implicated in learning, memory, and localized vasodilatation. However, the functions of Ang IV in a physiological context are still unknown. In this study, we generated a transgenic (TG) mouse model that chronically releases Ang IV peptide specifically in the brain. TG mice were found to be hypertensive by the tail-cuff method as compared with control littermates. Treatment with the angiotensin-converting enzyme inhibitor captopril had no effect on blood pressure, but surprisingly treatment with the Ang II AT1 receptor antagonist candesartan normalized the blood pressure despite the fact that the levels of Ang IV in the brains of TG mice were only 4-fold elevated over the normal endogenous level of Ang peptides. Calcium mobilization assays performed on cultured CHO cells chronically transfected with the AT1 receptor confirm that low-dose Ang IV can mobilize calcium via the AT1 receptor only in the presence of Ang II, consistent with an allosteric mechanism. These results suggest that chronic elevation of Ang IV in the brain can induce hypertension that can be treated with angiotensin II AT1 receptor antagonists.

Key Words: angiotensin IV • transgenic model • hypertension • brain renin–angiotensin system

This article has been cited by other articles:

				K. Kotlo, S. Shukla, U. Tawar, R. A. Skidgel, and R. S. Danziger Aminopeptidase N reduces basolateral Na+-K+-ATPase in proximal tubule cells Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1047 - F1053. [Abstract] [Full Text] [PDF]

				H.-L. Li, Z.-G. She, T.-B. Li, A.-B. Wang, Q. Yang, Y.-S. Wei, Y.-G. Wang, and D.-P. Liu Overexpression of Myofibrillogenesis Regulator-1 Aggravates Cardiac Hypertrophy Induced by Angiotensin II in Mice Hypertension, June 1, 2007; 49(6): 1399 - 1408. [Abstract] [Full Text] [PDF]

				H.-L. Li, M.-L. Zhuo, D. Wang, A.-B. Wang, H. Cai, L.-H. Sun, Q. Yang, Y. Huang, Y.-S. Wei, P. P. Liu, et al. Targeted Cardiac Overexpression of A20 Improves Left Ventricular Performance and Reduces Compensatory Hypertrophy After Myocardial Infarction Circulation, April 10, 2007; 115(14): 1885 - 1894. [Abstract] [Full Text] [PDF]

				V. Jankowski, R. Vanholder, M. van der Giet, M. Tolle, S. Karadogan, J. Gobom, J. Furkert, A. Oksche, E. Krause, T. N. Anh Tran, et al. Mass-Spectrometric Identification of a Novel Angiotensin Peptide in Human Plasma Arterioscler Thromb Vasc Biol, February 1, 2007; 27(2): 297 - 302. [Abstract] [Full Text] [PDF]

				X. C. Li, D. J. Campbell, M. Ohishi, S. Yuan, and J. L. Zhuo AT1 receptor-activated signaling mediates angiotensin IV-induced renal cortical vasoconstriction in rats Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1024 - F1033. [Abstract] [Full Text] [PDF]

				I. Haulica, W. Bild, and D. N Serban Review: Angiotensin Peptides and their Pleiotropic Actions Journal of Renin-Angiotensin-Aldosterone System, September 1, 2005; 6(3): 121 - 131. [Abstract] [PDF]